drugset / Trial / NCT02619201

Antiemetic Efficacy of Ondansetron Versus Metoclopramide

NCT02619201

RandomizedParallel-groupDouble-blindTreatment

Summary

Acute gastroenteritis (GEA) is a public health problem at present, the main cause of vomiting and consultation in emergencies in children under 5 years. Worldwide, there are about 2 million deaths per year due to gastroenteritis in children under 5 years. In Mexico, the mortality rate by age in 2013, recorded 28 deaths per 100,000 boys and girls, in 2013 in our country 2.5 million children between 5 and 17 years engaged in an economic activity. The occupancy rate for the child population was 8.6: 11.4 for boys and 5.8 for girls. NICE guidance gastroenteritis defined as a transient disorder caused by an enteric infection and characterized by a sudden onset of diarrhea with or without vomiting

Timeline

Start
2015-11
Primary completion
2016-05
Completion
2016-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metoclopramide Small molecule 0.15 mg/kg Intravenous
Subject Ondansetron Other / unclassified 0.15 mg/kg Intravenous

Indications